Integer (NYSE:ITGR) Now Covered by Analysts at Truist Financial

Investment analysts at Truist Financial started coverage on shares of Integer (NYSE:ITGR - Get Free Report) in a research report issued to clients and investors on Wednesday, MarketBeat reports. The brokerage set a "buy" rating and a $137.00 price target on the medical equipment provider's stock. Truist Financial's price target would suggest a potential upside of 16.42% from the company's previous close.

Other research analysts have also recently issued research reports about the company. Benchmark restated a "buy" rating and issued a $130.00 price target on shares of Integer in a research report on Friday, May 10th. Bank of America upgraded shares of Integer from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $105.00 to $135.00 in a research report on Monday, April 15th. KeyCorp increased their price target on shares of Integer from $123.00 to $139.00 and gave the company an "overweight" rating in a research report on Tuesday, April 9th. Finally, CL King began coverage on Integer in a research report on Thursday, March 14th. They set a "buy" rating and a $137.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, Integer presently has an average rating of "Moderate Buy" and a consensus price target of $128.67.

Integer Stock Performance

Integer stock traded up $5.67 during trading hours on Wednesday, reaching $117.68. 529,990 shares of the stock were exchanged, compared to its average volume of 334,760. Integer has a 52-week low of $69.40 and a 52-week high of $123.99. The stock has a market cap of $3.94 billion, a P/E ratio of 40.73, a P/E/G ratio of 1.67 and a beta of 1.12. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.01 and a current ratio of 3.32. The firm's 50 day moving average is $114.76 and its 200 day moving average is $103.26.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.12 by $0.02. Integer had a return on equity of 11.25% and a net margin of 6.01%. The business had revenue of $414.80 million during the quarter, compared to the consensus estimate of $412.78 million. During the same period in the prior year, the business posted $0.87 EPS. The company's revenue for the quarter was up 9.5% on a year-over-year basis. Analysts predict that Integer will post 5.27 EPS for the current fiscal year.

Insider Buying and Selling at Integer

In other Integer news, VP Tommy P. Thomas sold 1,500 shares of the firm's stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total value of $171,000.00. Following the transaction, the vice president now directly owns 2,813 shares of the company's stock, valued at $320,682. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, VP Tommy P. Thomas sold 1,500 shares of Integer stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total transaction of $171,000.00. Following the sale, the vice president now directly owns 2,813 shares of the company's stock, valued at $320,682. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP John A. Harris sold 312 shares of Integer stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $113.00, for a total value of $35,256.00. Following the sale, the executive vice president now directly owns 1,157 shares in the company, valued at $130,741. The disclosure for this sale can be found here. Insiders have sold 6,812 shares of company stock valued at $771,956 over the last three months. 2.00% of the stock is owned by company insiders.

Hedge Funds Weigh In On Integer

Hedge funds have recently bought and sold shares of the company. Handelsbanken Fonder AB grew its position in shares of Integer by 1.7% during the fourth quarter. Handelsbanken Fonder AB now owns 5,837 shares of the medical equipment provider's stock worth $578,000 after acquiring an additional 100 shares during the last quarter. Cornercap Investment Counsel Inc. grew its holdings in Integer by 1.0% in the 4th quarter. Cornercap Investment Counsel Inc. now owns 12,014 shares of the medical equipment provider's stock worth $1,190,000 after buying an additional 121 shares in the last quarter. Arizona State Retirement System raised its stake in Integer by 1.4% during the 3rd quarter. Arizona State Retirement System now owns 9,474 shares of the medical equipment provider's stock valued at $743,000 after acquiring an additional 131 shares in the last quarter. Quadrant Capital Group LLC boosted its position in Integer by 10.2% during the 4th quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider's stock worth $141,000 after acquiring an additional 132 shares during the period. Finally, Janney Montgomery Scott LLC grew its stake in shares of Integer by 1.5% in the third quarter. Janney Montgomery Scott LLC now owns 9,507 shares of the medical equipment provider's stock worth $746,000 after purchasing an additional 142 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.